CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 28 enrolled
Drug / intervention
3M CHG/IPA Prepdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03681990
NCT03681990Phase 2Completed
CompareCT.gov

Evaluation of Microbial Population Reductions Within a Defined Product Coverage Area

Solventum US LLC·interventional·Posted Sep 24, 2018·Updated Oct 2, 2024

In Brief

A Phase 2 clinical trial evaluating 3M CHG/IPA Prep for Surgical Skin Preparation and Surgical Procedure, Unspecified. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This study evaluates reduction of resident flora produced by the test product within a defined prepped area of skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgical Skin Preparation, Surgical Procedure, Unspecified
CountriesRomania
Collaborators3M

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedSep 24, 2018
Enrollment StartJun 6, 2017
Primary CompletionJul 4, 2017
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 7.8 years ago

Interventions

3M CHG/IPA Prepdrug

Apply topically to intact skin